BRAFTOVI (encorafenib) capsules Logo (WIPO, 07/16/2018)
WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark BRAFTOVI (encorafenib) capsules was filed as Figurative mark on 07/16/2018 at the World Intellectual Property Organization.
Logodesign (Wiener Klassifikation)
#Signs, notations, symbols #Circles #Letters presenting a special form of writing #Punctuation marks, brackets, quotation marks #26.01.01 #Several circles, juxtaposed, tangential or intersecting #Circles with dark surfaces or parts of surfaces #Series of letters presenting different forms of writing
| Trademark form | Figurative mark |
| File reference | 1428133 |
| Countries | 
|
| Base trademark |
No. 87756187,
January 16, 2018
|
| Application date | July 16, 2018 |
| Expiration date | July 16, 2028 |
Trademark owner
3200 Walnut Street
Boulder CO 80301
US
Boulder CO 80301
US
Trademark representatives
C/ Bilbao 1, 5°
E-03001 Alicante
ES
goods and services
05
Anti-infectives; anti-inflammatories; antibacterial
pharmaceuticals; antibiotics; antifungal preparations;
antivirals; cardiovascular pharmaceuticals; dermatological
pharmaceutical products; inhaled pharmaceutical preparations
for the treatment of respiratory diseases and disorders;
pharmaceutical preparations acting on the central nervous
system; pharmaceutical preparations and substances for the
treatment of gastro-intestinal diseases; pharmaceutical
preparations for the treatment and prevention of diseases
and disorders of the autoimmune system, the metabolic
system, the endocrine system, the musculo-skeletal system
and the genitourinary system; pharmaceutical preparations
for use in hematology and in tissue and organ
transplantation; pharmaceutical preparations for the
treatment of eye diseases and conditions; pharmaceutical
preparations for the treatment of heart rhythm disorders;
pharmaceutical preparations for the treatment of immune
system related diseases and disorders; pharmaceutical
preparations for the treatment of kidney diseases;
pharmaceutical preparations for treating diabetes;
pharmaceutical preparations for treating hypertension;
pharmaceutical preparations for treating skin disorders;
pharmaceutical preparations for use in dermatology;
pharmaceutical preparations for use in urology;
pharmaceutical products for ophthalmological use;
pharmaceutical products for the prevention and treatment of
cancer and tumors; pharmaceutical products for the treatment
of bone diseases; pharmaceutical products for treating
respiratory diseases; pharmaceutical products for treating
respiratory diseases and asthma
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| August 30, 2021 | 2021/40 Gaz | US | RAW: Partial Ceasing Effect |
| April 9, 2020 | 2020/16 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| October 17, 2019 | 2019/42 Gaz | JP | Rejection |
| October 4, 2019 | 2019/41 Gaz | KR | Rejection |
| August 1, 2019 | 2019/32 Gaz | IL | Rejection |
| July 16, 2018 | 2018/39 Gaz | US | Registration |
ID: 141428133